Isabelle Gusev
Principal Scientist & Group Leader, Analytical Development, CMC Tessera Therapeutics
Dr. Isabelle Gusev is Principal Scientist and Group Leader at TesseraTx, where she leads the development of advanced tools for LNP characterization. She earned her Ph.D. at Yale University under mentorship of Professor Csaba Horváth, the pioneer of HPLC technology. An expert in separation techniques and mass spectrometry, Dr. Gusev has extensive experience analysing biopolymers including oligonucleotides, proteins, ADCs, AAVs, LNPs, and peptides. She holds a patent on a peptide purification method developed for Taspoglutide (GLP-1 agonist) and has authored numerous scientific publications and presentations.
Seminars
Tuesday 7th April 2026
De-Risking LNP Stability through Advanced Analytical Strategies to Monitor Degradation & Optimize Shelf-Life
3:30 pm
- Identifying key degradation pathways and stress factors which impact LNP integrity
- Establishing reliable analytical methods to monitor stability of different LNP formulations
- Uncovering stability testing strategies to determine optimal storage conditions for extended shelf-life
NEW DATA
